Two Week Cross-Over Study Comparing Two Daily Disposable Contact Lenses

NCT ID: NCT01155323

Last Updated: 2018-06-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

118 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-01

Study Completion Date

2010-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study seeks to evaluate and compare the clinical performance of two daily disposable soft contact lenses, Proclear 1 Day and 1-Day Acuvue Moist.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

etafilcon A/omafilcon A

etafilcon A contact lenses will be worn during the first week and omafilcon A contact lenses will be worn during the second. Lenses were replaced daily

Group Type ACTIVE_COMPARATOR

etafilcon A

Intervention Type DEVICE

1-day soft contact lens

omafilcon A

Intervention Type DEVICE

1-day soft contact lens

omafilcon A/etafilcon A

omafilcon A contact lenses will be worn during the first week and etafilcon A contact lenses will be worn during the second. Lenses were replaced daily.

Group Type ACTIVE_COMPARATOR

etafilcon A

Intervention Type DEVICE

1-day soft contact lens

omafilcon A

Intervention Type DEVICE

1-day soft contact lens

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

etafilcon A

1-day soft contact lens

Intervention Type DEVICE

omafilcon A

1-day soft contact lens

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age and no more than 39 years of age
* Existing soft contact lens wearers
* Willing to signed a written Informed Consent.
* Own a mobile phone and are willing to receive and reply to Short Message Service (SMS) messages during the day.
* Have a contact lens spherical distance requirement between -1.00 diopters (D) and -6.00 diopters (D) in both eyes.
* Have an Astigmatism of 1.00D or less in both eyes.
* Require a visual correction in both eyes.
* Be correctable to a visual acuity of 6/9 (20/30) or better in each eye.
* Have normal eyes with no evidence of abnormality or disease that would preclude lens wear.

Exclusion Criteria

* Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, tarsal abnormalities, bulbar infection, or any other abnormality of the cornea that would contraindicate contact lens wear.
* Clinically significant corneal staining (Grade 3 in more than one region).
* Keratoconus or other corneal irregularity.
* Abnormal lachrymal secretions.
* Extended wear of contact lenses last 3 months.
* Polymethyl methacrylate (PMMA) or rigid gas-permeable (RGP) lens wear in the previous 8 weeks.
* Refractive surgery.
* Eye injury/surgery within 8 weeks immediately prior to enrollment for this study.
* Pre-existing ocular irritation that would preclude contact lens fitting.
* Require concurrent ocular medication
* Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
* Any infectious disease (e.g., hepatitis, tuberculosis) or any immunosuppressive disease (e.g., HIV).
* Diabetes.
* Pregnant, lactating or planning a pregnancy at the time of enrollment.
* Participation in any concurrent clinical trial or in last 30 days.
Minimum Eligible Age

18 Years

Maximum Eligible Age

39 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johnson & Johnson K.K. Medical Company

INDUSTRY

Sponsor Role collaborator

Visioncare Research Ltd.

OTHER

Sponsor Role collaborator

Johnson & Johnson Vision Care, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Danny Sim, Diploma in Optometry

Role: PRINCIPAL_INVESTIGATOR

Singapore Polytechnic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Singapore Plytechnic

Singapore, , Singapore

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DISP-523

Identifier Type: OTHER

Identifier Source: secondary_id

CR-0926

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.